Davis R M Inc Novo Nordisk A S Transaction History

Davis R M Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$102.11 - $135.92 $159,597 - $212,442	1,563 New	1,563 $200,000
Q2 2023 Aug 10, 2023	BUY	$155.98 - $172.65 $3,743 - $4,143	24 Added 0.53%	4,586 $742,000
Q1 2023 May 01, 2023	SELL	$132.34 - $159.14 $14,954 - $17,982	-113 Reduced 2.42%	4,562 $726,000
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $31,790 - $41,952	310 Added 7.1%	4,675 $633,000
Q3 2022 Nov 08, 2022	BUY	$95.28 - $116.93 $9,813 - $12,043	103 Added 2.42%	4,365 $435,000
Q2 2022 Aug 08, 2022	BUY	$103.24 - $121.81 $11,562 - $13,642	112 Added 2.7%	4,262 $475,000
Q1 2021 May 10, 2021	SELL	$67.06 - $75.82 $16,161 - $18,272	-241 Reduced 5.49%	4,150 $280,000
Q4 2020 Jan 27, 2021	SELL	$63.89 - $73.8 $6,389 - $7,380	-100 Reduced 2.23%	4,391 $307,000
Q1 2020 Apr 24, 2020	BUY	$49.46 - $64.78 $11,919 - $15,611	241 Added 5.67%	4,491 $270,000
Q3 2019 Oct 24, 2019	SELL	$47.54 - $53.43 $20,204 - $22,707	-425 Reduced 9.09%	4,250 $220,000
Q2 2018 Jul 19, 2018	SELL	$44.29 - $50.42 $25,466 - $28,991	-575 Reduced 10.95%	4,675 $216,000
Q1 2018 Apr 19, 2018	SELL	$48.49 - $58.14 $49,702 - $59,593	-1,025 Reduced 16.33%	5,250 $259,000
Q3 2017 Oct 24, 2017	BUY	$41.15 - $49.22 $258,216 - $308,855	6,275	6,275 $302,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $200B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Davis R M Inc, based on Form 13F filings with the SEC.

Stay updated on Davis R M Inc with notifications on news.